Understanding the interaction of genes and drugs
Russ Altman - Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine (General Medical Discipline), and (by courtesy) of Computer Science
Bio-X Affiliated Faculty
Russ Biagio Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing (AI, data science and informatics) to problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels.
Other Stanford Bio-X Supported Research
Human induced pluripotent stem cell-derived cardiomyocytes for cardiac drug testing
Supported BioSTAR Sponsored Research Project - 2013
Research News
$25 million awarded to center for study of regulatory science
November 17, 2016 - Stanford Medicine News Center
The FDA is funding a collaboration between Stanford and UCSF to improve the regulatory...
How data can help us understand cancer and its treatment
July 27, 2016 - Stanford Engineering
The dream, say Bio-X affiliates Jan Liphardt and Russ Altman, is to have cancer-relevant medical data flow...
Technique could ID patients who would suffer heart damage from chemo
April 18, 2016 - Stanford Medicine News Center
Bio-X affiliates Joseph Wu, Joshua Knowles, Helen Blau, Daniel Bernstein, and Russ Altman are...